1. Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study. (February 2017) Authors: Del Prete, Salvatore; Cennamo, Gregorio; Leo, Luigi; Montella, Liliana; Vincenzi, Bruno; Biglietto, Maria; Andreozzi, Francesca; Prudente, Antonella; Iodice, Patrizia; Savastano, Clementina; Nappi, Anna; Montesarchio, Vincenzo; Addeo, Raffaele Journal: Future oncology Issue: Volume 13:Number 5(2017) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. (March 2021) Authors: Ottaiano, Alessandro; Scala, Stefania; Santorsola, Mariachiara; Trotta, Anna Maria; D'Alterio, Crescenzo; Portella, Luigi; Clemente, Ottavia; Nappi, Anna; Zanaletti, Nicoletta; De Stefano, Alfonso; Avallone, Antonio; Granata, Vincenza; Notariello, Carmen; Luce, Amalia; Lombardi, Angela; Picone, C... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells. Issue 9 (29th May 2013) Authors: Martinelli, Erika; Troiani, Teresa; D'Aiuto, Elena; Morgillo, Floriana; Vitagliano, Donata; Capasso, Anna; Costantino, Sarah; Ciuffreda, Loreta Pia; Merolla, Francesco; Vecchione, Loredana; De Vriendt, Veerle; Tejpar, Sabine; Nappi, Anna; Sforza, Vincenzo; Martini, Giulia; Berrino, Liberato; De P... Journal: International journal of cancer Issue: Volume 133:Issue 9(2013:Nov. 01) Page Start: 2089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CXCR4–CXCL12–CXCR7, TLR2–TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients. (1st December 2016) Authors: D'Alterio, Crescenzo; Nasti, Guglielmo; Polimeno, Marianeve; Ottaiano, Alessandro; Conson, Manuel; Circelli, Luisa; Botti, Giovanni; Scognamiglio, Giosuè; Santagata, Sara; De Divitiis, Chiara; Nappi, Anna; Napolitano, Maria; Tatangelo, Fabiana; Pacelli, Roberto; Izzo, Francesco; Vuttariello, Emil... Journal: Oncoimmunology Issue: Volume 5:Number 12(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer. Issue 4 (16th August 2019) Authors: Cardone, Claudia; Martinelli, Erika; Troiani, Teresa; Sforza, Vincenzo; Avallone, Antonio; Nappi, Anna; Montesarchio, Vincenzo; Andreozzi, Francesca; Biglietto, Maria; Calabrese, Filomena; Bordonaro, Roberto; Cordio, Stefano; Bregni, Giacomo; Febbraro, Antonio; Garcia-Carbonero, Rocio; Feliu, Jai... Journal: ESMO open Issue: Volume 4:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol. (August 2020) Authors: Avallone, Antonio; Piccirillo, Maria Carmela; Di Gennaro, Elena; Romano, Carmela; Calabrese, Filomena; Roca, Maria Serena; Tatangelo, Fabiana; Granata, Vincenza; Cassata, Antonio; Cavalcanti, Ernesta; Maurea, Nicola; Maiolino, Piera; Silvestro, Lucrezia; De Stefano, Alfonso; Giuliani, Francesco; ... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗